Member Info for Bella6532

Looks like May will give us the YE Results, Nasdaq listing announcement, Coris sale completion and Qtry updates from now on and the next one will include AVA6000 data (end June)...that's my take from this RNS.

And the put this immedistely before results news...

....'where he led the company's 2014 initial public offering ("IPO") on Nasdaq.'

Are the two related...ie Nasdaq listing to be announced in May too...????

Why put these two updates right at the end...the rest is not news it's just repeating what has been said before...mmmm!!!!

As IBrian Hahn as Chief Financial Officer ("CFO"). Brian is a seasoned CFO with over 25 years' biopharma financial and operational experience. He spent 15 years as CFO and Senior Vice President of GlycoMimetics, Inc., where he led the company's 2014 initial public offering ("IPO") on Nasdaq.

Notice of 2024 Preliminary Results

'Avacta expects to report its Preliminary Results for the 12 months ended 31 December 2024 during May' 2025 suspected...later this year...

Saint68...haha..a minor detail hun...stick splits are great as they often keep the SP in an affordable range/make it look more attractive for new investors etc without the existing sharholders losing out. A 2 for 1 means your holding is doubled but the value of each share is halved so the net result is the same. A win win...

Most of the new big boys have started 'disrupter' businesses...Ask yourself is Avacta a 'disrupter'? and Do you Feel Lucky? because early stage investing is just that...LUCK!!!!

1 June 2010 Tesla listed on Nasdaq at around $1.50....today the SP is $263...hands up those who are willing to wait a few more years for the big bucks...or are you just going to winge. Guess that's the difference between wingers and serious long term investors.

Normally issued in April but they have up to 6 months. Will results be held back to coincide with trial data being released and Coris deal or will they simply issue RNSs as events happen...

Who doesn't want to take on DX businesses...Pharma or Funds...

A specialised fund is more likely to not want to invest in a TX/DX business...so the unnamed but mention specialised investor who came in during the last fundraiser...are they calling the shots re divesting DX.

Https://avacta.com/investors/key-information/

Remove Launch and add new Broker...

Agsin I ask...why sell a profitable side of the business without a potential deal...chicken and egg...unless they have a firm commitment already...

'Importantly, in the clinic AVA6000 has demonstrated the profile of a pre|CISION® medicine with three key findings: (1) a significant reduction in the observed toxicities associated with conventional doxorubicin, (2) the capacity to shrink tumors with multiple, durable responses observed in different disease settings with sensitivity to doxorubicin and (3) the profound concentration of the active payload (doxorubicin) in the tumor versus the plasma. Together, these findings in the clinic underscore the potential for the next assets in the pipeline to be highly differentiated and have potential for enhanced activity compared with traditional oncology therapeutics. '

Sorry TheGord...ignore that post please...t'was the total of the last 3 trades not one trade...I was on wrong time scale...derr!!...need a beer to lube the brain cells...

16:35. 139k...??

Gingethewinge...agree..looks like they took out a ruck of limit orders and/or 10 percenters made a quick buck...

At these levels it's easy to trade.

10 percenters

You never know!! 🤣

P18 in new file gives launch dates...indications...pricing etc

All launches will be in US first...Global second...

All will need to be well funded between now and then. Can we assume they are lookkng to US for funding based on above? Either a US based Pharma or via US Listing

Example from dome years ago...this one came righg out of the blue with no previous TR1's. They just quietly purchased shares on the open market over quite a lengthy period.

'DSM Venturing, the corporate venturing unit of Royal DSM N.V., today announces that it has acquired an equity stake of 29.3% in Provexis plc, an AIM listed company that develops and licenses ingredients for the functional food, medical food and dietary supplement market. The investment makes DSM the largest shareholder of Provexis.'

JFK8...what is your definition of a roll over...?

Apologies for typos...in a bit of a hurry right now...

Not sure if it's a toll over...

Bit too early for forward buying against Loan.

Lots of negs over past few days trying to keep SP down. Could be shorts closing but why put through in the day and not as late trades which is when they usually do.

Or is it second part of large order connected to the 3m ones and reason why we didn't get TR1 as order wasn't complete which is what happens.

Now what about the Coris sale...will we get announcement tomorrow?

Is the buying related to an Investor.

Is the SP being held yo facilitate a buy in...again it happens...

Why the new broker...have they brought someone to the table.

Problem is...this is all guess work znd we really don't know...but I go back to the fact CC has been very clear about investment/partnerships are predicated on Avacta being a pure play TX company...who whispered that narrative in her ear??? Would they have dumped DX (good for cash flow and contacts) if they weren't really sure they had something to replace it like a deal and/or funding or are they going to rely sorry on a US listing.

08:56....630k ???